HCA Healthcare (NYSE:HCA) Cut to “Underweight” at Wells Fargo & Company

HCA Healthcare (NYSE:HCA) was downgraded by investment analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a research report issued on Monday, MarketBeat reports. They currently have a $320.00 target price on the stock, down from their prior target price of $400.00. Wells Fargo & Company‘s target price suggests a potential downside of 2.72% from the stock’s previous close.

HCA has been the subject of a number of other research reports. UBS Group upped their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. TD Cowen cut their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. KeyCorp dropped their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Price Performance

NYSE HCA opened at $328.95 on Monday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market cap of $83.32 billion, a P/E ratio of 14.77, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. The stock’s 50-day moving average is $376.47 and its two-hundred day moving average is $358.74. HCA Healthcare has a fifty-two week low of $245.84 and a fifty-two week high of $417.14.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.60% of the stock is owned by insiders.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors have recently made changes to their positions in the stock. Terra Nova Asset Management LLC increased its stake in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after purchasing an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its stake in HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after buying an additional 29 shares during the period. Waldron Private Wealth LLC increased its holdings in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after acquiring an additional 29 shares in the last quarter. Brookstone Capital Management grew its position in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. raised its holdings in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.